TY - JOUR
T1 - Praktische Anwendung digitaler Gesundheitsanwendungen (DiGA) in der Inneren Medizin
AU - AG DiGA und KI in Leitlinien der Kommission Digitale Transformation der DGIM
AU - Mittermaier, Mirja
AU - Sina, Christian
AU - Richter, Jutta G.
AU - Raspe, Matthias
AU - Stais, Patrick
AU - Vehreschild, Jörg
AU - Wolfrum, Sebastian
AU - Anthes, Christina
AU - Möckel, Martin
N1 - Funding Information:
Wir danken Herrn Dr. Philipp Stachwitz, hih?? health innovation hub, Bundesministerium f?r Gesundheit, f?r seine hilfreichen Anregungen bei der ?berarbeitung des Manuskripts.
Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
PY - 2022/3
Y1 - 2022/3
N2 - Since 2020 physicians can prescribe digital health applications (DiGA), also colloquially known as apps on prescription, which are reimbursed by the statutory health insurance when they are approved by the Federal Institute for Drugs and Medical Devices (BfArM) and are included in the DiGA Ordinance. Currently, there is one approved DiGA (indication obesity) for internal medicine. There are many questions on the practical use of the DiGA, ranging from the prescription, the effectiveness, the complexities and reimbursement as well as the liability risks. The DiGA are innovative new means, which maybe support internal medicine physicians in the diagnostics and treatment in the future. The benefits in this field of indications are limited by unclarified issues, especially on the prescription practice and the currently low number of DiGA available in internal medicine.
AB - Since 2020 physicians can prescribe digital health applications (DiGA), also colloquially known as apps on prescription, which are reimbursed by the statutory health insurance when they are approved by the Federal Institute for Drugs and Medical Devices (BfArM) and are included in the DiGA Ordinance. Currently, there is one approved DiGA (indication obesity) for internal medicine. There are many questions on the practical use of the DiGA, ranging from the prescription, the effectiveness, the complexities and reimbursement as well as the liability risks. The DiGA are innovative new means, which maybe support internal medicine physicians in the diagnostics and treatment in the future. The benefits in this field of indications are limited by unclarified issues, especially on the prescription practice and the currently low number of DiGA available in internal medicine.
UR - http://www.scopus.com/inward/record.url?scp=85123241732&partnerID=8YFLogxK
U2 - 10.1007/s00108-022-01264-5
DO - 10.1007/s00108-022-01264-5
M3 - Übersichtsarbeiten
C2 - 35037948
AN - SCOPUS:85123241732
SN - 0020-9554
VL - 63
SP - 245
EP - 254
JO - Internist
JF - Internist
IS - 3
ER -
